Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Immunoreactive forms of human erythrocyte ankyrin are present in diverse cells and tissues

Abstract

Ankyrin is a polypeptide of molecular weight (MW) 200,000 which is tightly bound to the cytoplasmic surface of the human erythrocyte membrane and has been identified as the high-affinity membrane attachment protein for spectrin1–3. This protein has also been shown to be associated with band 3 (ref. 4), the major transmembrane protein in erythrocytes. Ankyrin is thus an example of a polypeptide which links a cytoplasmic structural protein to an integral membrane protein. A water-soluble, 72,000-MW, proteolytic fragment of ankyrin has been purified which retains the ability to bind to spectrin, and competitively inhibits reassociation of spectrin with membranes5. Monospecific antibodies directed against this fragment have been prepared1 and demonstrated to cross-react only with ankyrin among the erythrocyte membrane proteins1,4. The present study reports the use of these antibodies to develop a radioimmunoassay capable of detecting femtomolar quantities of ankyrin, and demonstrates the presence of small but significant amounts of immunoreactivity in a variety of types of cells and tissues.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Bennett, V. & Stenbuck, P. J. J. biol. Chem. 254, 2533–2541 (1979).

    CAS  PubMed  Google Scholar 

  2. Luna, E. J., Kidd, G. H. & Branton, D. J. biol. Chem. 254, 2526–2532 (1979).

    CAS  PubMed  Google Scholar 

  3. Yu, J. & Goodman, S. Proc. natn. Acad. Sci. U.S.A. 76, 2340–2344 (1979).

    Article  ADS  CAS  Google Scholar 

  4. Bennett, V. & Stenbuck, P. J. Nature 280, 468–413 (1979).

    Article  ADS  CAS  Google Scholar 

  5. Bennett, V. J. biol. Chem. 253, 2292–2299 (1978).

    CAS  PubMed  Google Scholar 

  6. Hunter, W. M. & Greenwood, F. C. Nature 194, 495 (1962).

    Article  ADS  CAS  Google Scholar 

  7. Goding, J. W. J. immun. Meth. 18, 183–192 (1978).

    Google Scholar 

  8. Bennett, V. & Branton, D. J. biol. Chem. 252, 2753–2763 (1977).

    CAS  PubMed  Google Scholar 

  9. Steck, T. L. J. Cell Biol. 62, 1–19 (1974).

    Article  CAS  Google Scholar 

  10. Boyam, A. Scand. J. clin. Lab. Invest. 21, Suppl. 97, 77–89 (1968).

    Article  Google Scholar 

  11. Perper, R. J., Zee, T. W. & Mickelson, M. M. J. Lab. clin. Med. 72, 842–849 (1968).

    CAS  PubMed  Google Scholar 

  12. Rodbell, M. J. biol. Chem. 239, 375–380 (1964).

    CAS  Google Scholar 

  13. Fairbanks, G., Steck, T. L. & Wallach, D. F. H. Biochemistry 10, 2606–2617 (1971).

    Article  CAS  Google Scholar 

  14. Hiller, G. & Weber, K. Nature 266, 181–183 (1977).

    Article  ADS  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bennett, V. Immunoreactive forms of human erythrocyte ankyrin are present in diverse cells and tissues. Nature 281, 597–599 (1979). https://doi.org/10.1038/281597a0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/281597a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing